Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells

Feng Xu1, Zhi-Gang Ou-Yang, Sheng-Hua Zhang

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Abstract

Insights

Sodium caffeate (SCA) induces endothelial cell apoptosis and suppresses VEGF expression and type IV collagenase activity in cancer cells. This suggests SCA may be effective in modulating tumor angiogenesis and the tumor microenvironment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor angiogenesis is crucial for cancer growth and metastasis.
  • Vascular Endothelial Growth Factor (VEGF) plays a key role in angiogenesis.
  • Type IV collagenase activity, including MMP-2 and MMP-9, is essential for extracellular matrix degradation during tumor invasion.

Purpose of the Study:

  • To investigate the effects of sodium caffeate (SCA) on endothelial cell apoptosis.
  • To determine SCA's impact on VEGF expression in cancer cells.
  • To assess SCA's inhibitory effects on type IV collagenase activity.

Main Methods:

  • Endothelial cell apoptosis was assessed using flow cytometry, DNA electrophoresis, and morphological analysis.
  • VEGF expression was quantified via Western blotting.
  • Type IV collagenase activity and antibody binding were measured using zymography and ELISA.

Main Results:

  • Sodium caffeate (SCA) induced apoptosis in human umbilical vein endothelial cells (ECV304) in a dose- and time-dependent manner.
  • SCA treatment significantly reduced VEGF expression in hepatoma (HepG-2) and prostate carcinoma (DU145) cells.
  • SCA inhibited the degradation activity of type IV collagenases (MMP-2, MMP-9) secreted by pulmonary carcinoma (PG) cells.

Conclusions:

  • Sodium caffeate (SCA) demonstrates potent pro-apoptotic effects on endothelial cells.
  • SCA effectively suppresses VEGF expression and type IV collagenase activity in various cancer cells.
  • These findings indicate SCA's potential as an anti-angiogenic agent for cancer therapy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...